Research area: Clinical Sciences > Neurodisability and Rehabilitation

Overview

Each autistic person is unique and experiences autism differently.

Difficulties with communication and social interaction are characteristics of autism. There are no approved medications to assist with communication and social interaction. This is why we aim to find new and different ways to improve the challenges faced by autistic individuals.

The IRIS study aims to discover whether a medication can improve the social and communication challenges that autistic people might experience.

We hope that the information learned from this study will help find new treatment options for autistic individuals in the future.

Information for participants

To qualify for this autism research study, participants must:

• Be 12 to 18 years of age
• Have a diagnosis of autism spectrum disorder
• Have a parent, relative, housemate, friend, or other study partner to assist during the study and attend clinic visits

If you or your loved one would like to take the next step toward possible participation in the IRIS study or if you have more questions, please get in touch. Participation in the IRIS study is voluntary, and you may withdraw your consent at any time for any reason. Contacting us does not obligate you to participate in this study.

There are additional requirements for participation. Our team will explain the complete list of participation requirements. There is no cost to participate and compensation for travel may be available.

What happens during the study?

Study involvement takes six months and includes four months on the study drug (either ML-004 or placebo). The study includes 10 visits to The Royal Children’s Hospital for medical review and psychology assessment, blood and urine tests, and ECGs.

Important note: This is a double-blind randomised control trial which means children will be randomly assigned to receive ML-004 or a Placebo. Neither you nor the study team will know which group your child is in.

Contact us

IRIS Study
Dr Kylie Crompton 
Research Officer 
Phone: +61 3 9936 6756
Email:  show email address